Story perspectives
Revolutionary Nasal Spray Antibody Fights Influenza A Mutations
5/8/2025
50 12
1 of 1
Story summary
- A groundbreaking monoclonal antibody developed by researchers at The Ohio State University offers hope in the fight against lethal influenza A. Administered through a nasal spray, this innovative IgM-based antibody effectively neutralizes viruses, even after they mutate. This promising study could pave the way for new defenses against seasonal flu and future pandemics, with broader implications for various diseases.
